BMP1 Epigenetic Signatures Predict Muscle Strength in Postmenopausal Women
A multiomics study links BMP1 methylation patterns and novel SNPs to muscle strength and bone health in women aged 50–70.
Summary
Researchers studied 141 postmenopausal women using genome-wide genotyping and DNA methylation arrays to uncover molecular drivers of muscle strength. They identified 12 SNPs and 12 differentially methylated regions associated with strength phenotypes. Notably, higher BMP1 epigenetic scores correlated with greater muscle strength, while in weaker women, BMP1 scores inversely correlated with femoral neck bone density. A polygenic risk score predicted strength group membership with modest accuracy. A meta-analysis of public muscle transcriptomes further confirmed that resistance training boosts BMP1 expression. These findings suggest BMP1 plays a dual role in muscle-bone crosstalk and may serve as an epigenetic biomarker for musculoskeletal aging in older women.
Detailed Summary
As women age past menopause, declining muscle strength accelerates frailty and bone loss — yet the molecular mechanisms governing individual variability in strength have remained poorly understood. This study addresses that gap using a sophisticated multiomics approach combining genetics, epigenetics, and transcriptomics.
A cohort of 141 postmenopausal women aged 50–70 underwent comprehensive functional assessments, bone density scans, and biochemical profiling. Participants were split into higher- and lower-strength groups based on validated upper and lower limb tests. Genome-wide genotyping (Illumina Global Screening Array) and DNA methylation profiling (Illumina EPIC 850K array) were performed, with polygenic risk scores developed in a training set (n=100) and validated in a holdout group (n=41).
Twelve SNPs emerged as associated with strength phenotypes, and the resulting polygenic risk score achieved 51.2% classification accuracy — modest but notable for this complex trait. Epigenetic analysis identified 12 differentially methylated regions, with BMP1 (bone morphogenetic protein 1) epigenetic scores standing out: higher scores tracked with greater muscle strength. In the lower-strength group, BMP1 EpiScores inversely correlated with femoral neck T-scores (r = -0.66), hinting at disrupted bone-muscle crosstalk. Pathway enrichment pointed to bone remodeling and vascular regulation mechanisms.
A meta-analysis of public transcriptomic datasets confirmed that resistance training elevates BMP1 muscle expression, reinforcing its biological relevance to exercise adaptation. Fitness-related epigenetic clocks (DNAmGrip, DNAmGait, DNAmVO2max, DNAmFitAge) were also applied, enriching the phenotypic picture.
These findings position BMP1 as a promising epigenetic biomarker and potential therapeutic target at the muscle-bone interface. Caveats include the observational design, modest sample size, and the fact that only an abstract was available for review.
Key Findings
- 12 SNPs and 12 differentially methylated regions linked to muscle strength variability in postmenopausal women.
- Higher BMP1 epigenetic scores associated with greater muscle strength across participants.
- In low-strength women, BMP1 EpiScore inversely correlated with femoral neck bone density (r = -0.66).
- Resistance training meta-analysis confirmed BMP1 expression increases with exercise in muscle tissue.
- Polygenic risk score predicted strength group classification at 51.2% accuracy in a validation cohort.
Methodology
Cross-sectional study of 141 postmenopausal women (50–70 yrs) using Illumina genome-wide genotyping and EPIC 850K methylation arrays. Polygenic risk scores were trained on 100 participants and validated on 41. Epigenetic clocks and EpiScores were derived using MethylDetectR and methylclock packages.
Study Limitations
The study is observational and cross-sectional, limiting causal inference. The polygenic risk score achieved only 51.2% accuracy, indicating limited predictive power in isolation. Findings are restricted to postmenopausal women of likely homogeneous ancestry, reducing generalizability.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: